Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy
Diabetes Research and Clinical Practice Aug 05, 2019
Gao C, et al. - Because intrarenal Aquaporin 5 (AQP5) is upregulated in patients with diabetic nephropathy, researchers ascertained if urinary AQP5 is independently correlated with estimated glomerular filtration rate (eGFR) decline in patients with type 2 diabetes and nephropathy. Baseline urine samples were measured for AQP5 using enzyme-linked immunosorbent assays from 997 patients with type 2 diabetes and nephropathy of the sulodexide macroalbuminuria trial. Patients with AQP5's highest tertile had significantly higher total cholesterol, lower baseline eGFR, and higher albuminuria levels compared with the lowest tertile. Investigators found that AQP5 was inversely associated with eGFR slope, and independent of clinical risk factors age, sex, race, and baseline systolic and diastolic blood pressure, hemoglobin A1c, total cholesterol, eGFR, and urine albumin-to-creatinine ratio. Moreover, AQP5 was significantly linked to fast eGFR decline. In patients with type 2 diabetes and nephropathy, baseline AQP5 is independently linked to the progression of eGFR decline.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries